400 participants
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2021-10-25
- Completion:
- 2026-03-16
Conditions
- Advanced Non-small Cell Lung Cancer
- EGFR Mutation
- HER2 Mutation
Interventions
- DRUG
No Results Yet